In The Spotlight
DDNews Cancer Research Exclusive
Here's to more survivors
(Photo credit: National Cancer Institute)
Recent reports from cancer advocacy and research organizations detail an increase in cancer survivors, with incidence and mortality rates dropping in recent years
Agreement focuses on tafasitamab for the treatment of B cell malignancies
Shimadzu and Providence Cancer Institute team up to advance cancer immunotherapy research
Bio-Rad’s ddPCR technology provides faster, more accurate diagnoses
NeoGenomics acquires oncology operation from Human Longevity for $37 million
BioNTech announces publication of preclinical data for a CARVac targeting Claudin 6
Silverback Therapeutics’ SBT6050 shows promise in HER2-expressing tumors
Drug can affect non-Hodgkin’s lymphoma cell lines
Broad antitumor activity shown in immunocompetent models sensitive or resistant to immune checkpoint blockade
A look at gastroesophageal, gastric and colorectal cancer progress
by Martin Lachs/Brandon Fletcher
As excitement and investment related to adoptive cell transfer products increases, there are concerns and issues that need to be addressed in terms of long-term follow-up trials

by Sue Cramp, Charles River
In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

by Andrea Toell of Lonza
Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.